8VQ4
CDK2-CyclinE1 in complex with allosteric inhibitor I-125A.
This is a non-PDB format compatible entry.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 17-ID |
Synchrotron site | APS |
Beamline | 17-ID |
Temperature [K] | 98.15 |
Detector technology | PIXEL |
Collection date | 2023-02-08 |
Detector | DECTRIS EIGER X 9M |
Wavelength(s) | 1 |
Spacegroup name | P 41 21 2 |
Unit cell lengths | 101.374, 101.374, 151.607 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 45.230 - 1.900 |
R-factor | 0.193 |
Rwork | 0.192 |
R-free | 0.21860 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 7kjs |
RMSD bond length | 0.014 |
RMSD bond angle | 1.413 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | PHENIX (1.14_3260) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 84.271 | 2.055 |
High resolution limit [Å] | 1.842 | 1.896 |
Rmerge | 0.071 | 4.640 |
Number of reflections | 63226 | 329 |
<I/σ(I)> | 23.5 | |
Completeness [%] | 79.5 | 18.8 |
Redundancy | 12.4 | 11.4 |
CC(1/2) | 1.000 | 0.653 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 294 | 0.21 M sodium citrate tribasic dihydrate, 19.5% PEG3350 |